Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:SR
NYSE:SRGas Utilities

Assessing Spire (SR) Valuation After Recent Share Price Momentum And Earnings Multiple Signals

Spire (SR) has caught investors' attention after a recent share price move, with the stock closing at $92.65. That shift is prompting fresh interest in how its gas utility and related businesses are currently valued. See our latest analysis for Spire. The move to $92.65 is part of a broader upswing, with an 11.34% year to date share price return and a 21.97% total shareholder return over the past year indicating improving momentum for Spire. If you are looking beyond utilities for ideas, this...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

TMC The Metals Seeks U.S. Nodule Processing Path As Partnerships Grow

TMC the metals (NasdaqGS:TMC) signed an MoU with Deep Sea Rare Minerals to explore collaboration on U.S. processing of deep sea critical minerals. The company also entered a partnership with Mariana Minerals to support feasibility work and AI based process development for its planned Texas processing hub. Both agreements are aimed at advancing a domestic nodule processing ecosystem aligned with U.S. critical mineral supply priorities. TMC the metals is drawing attention again as it adds two...
NasdaqGS:CHKP
NasdaqGS:CHKPSoftware

A Look At Check Point Software Technologies (NasdaqGS:CHKP) Valuation After New AI Security Product Launches

AI security launches reshape the Check Point investment story Check Point Software Technologies (NasdaqGS:CHKP) has introduced its AI Defense Plane and AI Factory Security Architecture Blueprint, two offerings aimed at securing enterprise AI systems and private AI data centers as adoption and regulatory demands increase. For you as an investor, these moves highlight how Check Point is positioning its security portfolio around AI workloads, from employee use of AI apps to protection of GPU...
ASX:CBA
ASX:CBABanks

Should CBA’s Record Profit and A$1 Billion Fraud Probe Require Action From Commonwealth Bank of Australia (ASX:CBA) Investors?

Commonwealth Bank of Australia recently reported a record half-year cash profit of A$5.45 billion, lifted variable home and business loan rates after a Reserve Bank of Australia hike, and began probing up to A$1 billion in suspected AI-enabled fraudulent home loans referred to police. These results highlight the tension between CBA’s strong lending momentum and emerging risks from digital-era fraud and a more uncertain inflation and interest rate backdrop. We’ll now examine how CBA’s record...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

CDW Canada Flags Cloud Security Gaps As AI Threats Shape Growth

CDW Canada released a new cybersecurity study highlighting widespread gaps in enterprise cloud security. The report points to rising AI driven cyberattacks and increasing pressure on organizations to upgrade defenses. The findings underscore growing demand and risk considerations around CDW’s security and cloud offerings. CDW, traded as NasdaqGS:CDW, sits at a share price of $122.01 with a mixed recent return profile. The stock is down 8.4% year to date and 18.2% over the past year, with a...
NasdaqGS:TCOM
NasdaqGS:TCOMHospitality

A Look At Trip.com Group (NasdaqGS:TCOM) Valuation After Regulatory Probe And Investor Lawsuits

Regulatory probe and lawsuits put Trip.com Group in focus Trip.com Group (TCOM) is back in the spotlight after Chinese regulators opened an anti monopoly investigation into its AI price adjustment tool, followed by multiple U.S. securities class action lawsuits alleging inadequate disclosure of regulatory risks. See our latest analysis for Trip.com Group. The regulatory probe and class action headlines have coincided with a sharp shift in sentiment, with a 90 day share price return showing a...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

A Look At uniQure (QURE) Valuation After Its Sharp Recent Share Price Rebound

uniQure (QURE) has drawn fresh attention after a sharp move in its share price over the past month, in contrast with a weaker performance over the past 3 months. Investors are weighing this swing against the company’s gene therapy pipeline and recent financial figures. See our latest analysis for uniQure. The recent 90.03% 30 day share price return, on top of a 10% 7 day move and 1.60% gain in the last session, contrasts with a 26.64% year to date share price decline and a 76% 1 year total...
NYSE:DVN
NYSE:DVNOil and Gas

Is Devon’s Extended, Cheaper Credit Line Quietly Reframing Its Capital Allocation Playbook (DVN)?

On March 24, 2026, Devon Energy amended its syndicated credit facility, extending the maturity to March 24, 2031 and removing the 10 basis point SOFR credit spread adjustment while renewing options for three additional one-year extensions, subject to lender approval. This refinancing slightly lowers Devon’s borrowing costs and lengthens liquidity visibility, which can support capital allocation flexibility across commodity cycles. With this extended, lower-cost credit line in place, we’ll...
NasdaqGS:HBT
NasdaqGS:HBTBanks

Assessing HBT Financial (HBT) Valuation As Shares Deliver Solid Multi‑Period Returns

HBT Financial overview and recent performance snapshot HBT Financial (HBT) has drawn fresh attention as investors review its recent share performance and fundamentals, with the stock closing at $27.44 and showing positive total returns over the past 3 months and year. The Illinois based bank holding company reports revenue of $233.924 million and net income of $77.008 million, with annual revenue and net income growth rates of 17.38% and 18.78% respectively, and a reported market value of...
NYSE:NOC
NYSE:NOCAerospace & Defense

A Look At Northrop Grumman (NOC) Valuation After A Recent Share Price Pullback

Northrop Grumman Stock Snapshot Northrop Grumman (NOC) is drawing attention after recent share performance, with a last close of $702.50 and mixed returns over different periods, including a roughly 7% decline over the past month. See our latest analysis for Northrop Grumman. The recent pullback, with a 30 day share price return of around negative 7%, comes after strong momentum earlier in the year. This includes a 90 day share price return of almost 20% and a 1 year total shareholder return...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Assessing Corpay (CPAY) Valuation After Recent Share Price Pullback

Corpay at a glance Corpay (CPAY) has drawn fresh attention after recent trading left the shares about 12% lower over the past month and slightly lower over the past 3 months, despite a 3 year total return above 40%. See our latest analysis for Corpay. At around $293.34 per share, Corpay’s recent 12% 1 month share price pullback and slightly negative year to date share price return contrast with its 3 year total shareholder return above 40%. This suggests that momentum has cooled following a...
TSXV:PALI
TSXV:PALICapital Markets

Palisades Goldcorp (TSXV:PALI) Quarterly Net Income Of CA$86.8m Tests Skeptical Narratives

Palisades Goldcorp (TSXV:PALI) has just posted its FY 2025 third quarter numbers, with total revenue of CA$122 million and basic EPS of CA$1.35, alongside a trailing twelve month EPS of CA$0.66 and net income of CA$38 million. The company has seen quarterly revenue move from CA$0.22 million in Q2 FY 2024 to CA$1.26 million in Q3 FY 2024, then to CA$2.27 million in Q1 FY 2025, CA$7.18 million in Q2 FY 2025 and now CA$122 million in Q3 FY 2025. Over the same period, basic EPS shifted from a...
SWX:JFN
SWX:JFNTransportation

Jungfraubahn Holding (SWX:JFN) H1 Net Margin Of 25.9% Tests Premium Valuation Narrative

Jungfraubahn Holding (SWX:JFN) has reported its FY 2025 half year results with revenue of CHF 149.9 million and net income of CHF 37.1 million, translating to basic EPS of CHF 6.50. The trailing twelve month figures are CHF 302.7 million of revenue and CHF 78.5 million of net income with EPS of CHF 13.80. The company has reported revenue of CHF 141.8 million and EPS of CHF 6.07 in 2024 H1, and CHF 152.8 million and EPS of CHF 7.30 in 2024 H2. This sets up FY 2025 H1 against a backdrop where...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

A Look At SoFi Technologies (SOFI) Valuation After Launching Its Big Business Banking Platform

SoFi Technologies (SOFI) has rolled out its Big Business Banking platform, giving large enterprises a single, regulated place to manage both fiat and crypto activity, including SoFiUSD on Solana, with 24/7 API-based payments. See our latest analysis for SoFi Technologies. The launch of Big Business Banking comes after a volatile few months for the stock, with a 90 day share price return showing a 42.28% decline, but a 1 year total shareholder return of 48.97% and a 3 year total shareholder...
TSX:DTOL
TSX:DTOLConsumer Services

D2L (TSX:DTOL) Net Margin Expansion Reinforces Bullish Profitability Narratives

D2L (TSX:DTOL) has just posted another quarter of positive results, with Q3 FY 2026 revenue of US$54.1 million and basic EPS of US$0.08, supported by trailing twelve month net profit of US$30.2 million and EPS of US$0.55. Over the last five reported quarters, revenue has held in a tight band around US$49 million to US$55 million per quarter, while basic EPS has moved from a small loss in FY 2025 Q2 to US$0.36 in FY 2025 Q4 and stayed positive through FY 2026. With a trailing net margin of 14%...
NYSE:TSM
NYSE:TSMSemiconductor

Assessing Taiwan Semiconductor Manufacturing’s Valuation After A Year Of Strong Shareholder Returns

Recent performance snapshot for Taiwan Semiconductor Manufacturing (TSM) Taiwan Semiconductor Manufacturing (NYSE:TSM) has seen mixed share performance recently, with a 0.7% decline over the past day, a 4.0% gain over the past week, a 4.0% decline over the past month, and a 6.1% gain over the past 3 months. See our latest analysis for Taiwan Semiconductor Manufacturing. At a share price of US$339.04, Taiwan Semiconductor Manufacturing’s recent short term softness contrasts with a very strong...
NYSE:GE
NYSE:GEAerospace & Defense

Will Shareholder Activism Over Israel Ties Reshape General Electric's (GE) Defense-Focused Investment Narrative?

In late March 2026, JLens and the Anti-Defamation League urged GE Aerospace shareholders to oppose a proposal criticizing the company’s defense sales to Israel and calling for a human-rights due diligence report, arguing it could harm its defense business and misplace political debates in the boardroom. At the same time, GE Aerospace has drawn heightened analyst and investor attention as it reports strong operating results and expands partnerships, even as geopolitical tensions and security...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

Assessing Keurig Dr Pepper (KDP) Valuation After A Stretch Of Weaker Share Performance

Why Keurig Dr Pepper (KDP) Is Getting Attention Now Keurig Dr Pepper (KDP) has caught investor attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months and year. See our latest analysis for Keurig Dr Pepper. With the share price at US$25.31, recent trading has leaned negative, with a 30 day share price return showing a decline of 14.41% and a 1 year total shareholder return showing a decline of 26.58%, suggesting momentum...
TSX:LGO
TSX:LGOMetals and Mining

Largo (TSX:LGO) Quarterly Loss Of US$36.6m Reinforces Bearish Community Narratives

Latest FY 2025 earnings snapshot Largo (TSX:LGO) has just posted its FY 2025 third quarter numbers, with revenue of US$33.3 million and a basic EPS loss of US$0.57 capping off a period where trailing 12 month revenue sits at US$111.9 million against a loss of US$1.00 per share. Over recent quarters the company has seen revenue move from US$24.3 million in Q4 2024 to US$33.3 million in Q3 2025, while quarterly basic EPS losses ranged between US$0.09 and US$0.57. This pattern keeps the focus...
NYSE:WST
NYSE:WSTLife Sciences

A Look At West Pharmaceutical Services (WST) Valuation After New Dublin Expansion For Injectable Treatments

West Pharmaceutical Services (WST) has opened a 165,000 square foot expansion at its Damastown, Dublin site, adding advanced automation and commercial scale drug handling to support high volume injectable treatments for diabetes and obesity. See our latest analysis for West Pharmaceutical Services. The Dublin expansion has arrived while the share price has been under pressure in recent months, with a 90 day share price return of 7.81% decline but a 1 year total shareholder return of 16.24%,...
TSXV:ALV
TSXV:ALVOil and Gas

A Look At Alvopetro Energy (TSXV:ALV) Valuation After New Gas Contracts And Record Quarterly Production

Sales update and gas agreement set the context Alvopetro Energy (TSXV:ALV) is back on investor radars after reporting record quarterly sales volumes of 3,124 boepd, alongside an expanded firm natural gas sales agreement with Bahiagás covering 2026 and 2027. See our latest analysis for Alvopetro Energy. The share price has responded to this operational momentum, with a 30 day share price return of 16.89% feeding into a 40.43% year to date gain and a 1 year total shareholder return of 110.14%,...
NYSE:VRT
NYSE:VRTElectrical

Is It Too Late To Consider Vertiv (VRT) After Its Huge Multi Year Share Price Surge?

Wondering if Vertiv Holdings Co at US$261.29 is still priced for opportunity or already reflecting the story in full? This article walks through the numbers so you can judge the value for yourself. The stock has delivered returns of 3.5% over 7 days, 6.9% over 30 days, 48.8% year to date, 287.7% over 1 year and a very large gain over 3 and 5 years, which naturally raises questions about what is already priced in. Recent coverage has highlighted Vertiv in the context of power and data center...
TSX:IMO
TSX:IMOOil and Gas

Imperial Oil (TSX:IMO) Valuation Check After Upward Earnings Revisions And Recent Earnings Beats

Imperial Oil (TSX:IMO) is back in focus after analysts raised earnings estimates several times without any cuts, alongside a recent streak of earnings beats that has reinforced its positive momentum profile. See our latest analysis for Imperial Oil. Imperial Oil shares have moved sharply higher, with a 48.52% year to date share price return and a 92.30% one year total shareholder return, suggesting momentum is building as recent estimate upgrades and earnings beats shape sentiment. If you are...
NYSE:CVS
NYSE:CVSHealthcare

How CVS’s Shift to Smaller Pharmacy-Only Stores Will Impact CVS Health (CVS) Investors

In late March 2026, CVS Health opened its first apothecary-style, pharmacy-only CVS Pharmacy location in Chicago and outlined plans to add nearly 20 such neighborhood pharmacies plus more than 40 additional CVS Pharmacy sites, including stores inside Target, across the US this year. This shift toward smaller, pharmacy-focused formats marks a meaningful evolution in CVS Health’s retail footprint, emphasizing medication access, immunizations, and pharmacist-led care in communities with...